Therapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthritis ?
ALLIANCE
1 other identifier
observational
120
1 country
17
Brief Summary
to evalute if therapeutic alliance is related to adherence in JIA
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2016
17 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2016
CompletedFirst Posted
Study publicly available on registry
July 7, 2016
CompletedStudy Start
First participant enrolled
October 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedJuly 12, 2018
July 1, 2018
1.2 years
July 4, 2016
July 11, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Relationship between therapeutic alliance and compliance judged by the child ( CarQ Questionnaire) and parent ( PARQ Questionnaire).
Several questionnaires (6-8) measure the alliance in adults and have shown the link between early alliance and therapeutic efficacy and especially the need to measure not made by the therapist but by the treatment. Then the scores were developed in children where the alliance is special since the role of the adult, the parent is part of the monitoring and assistance to the acceptance of the disease and guarantee the continuity of care . Among them, the HQA I was designed to examine the child-parent-caregiver triad. The HQA-CP score (Helping questionnaires Alliance for Child and Parents) is derived from this score. HQA-CP was validated in French by Kermarrec et al.
at inclusion
Secondary Outcomes (1)
Quality of Life (CHAQ Questionnaire )
at inclusion
Eligibility Criteria
Children with Juvenile idiopathic arthritis (JIA) and aged from 8 to 18 years, that have been akready seen more than 2 times in consultation by the same practitioner. Treatment is based on the non-steroidal anti-inflammatory drugs, corticosteroids or immunosuppressant therapy and due to chronic nature of JIA, it requires a strong ability of the child to follow his treatment. The role of parents going to be important and the relationship built with the caregiver is essential. As much as in adults, and can be more complex way the question of adherence / therapeutic adherence.
You may qualify if:
- Patients with JIA (see classification above)
- Aged at least 8 to 18 years.
- Having already seen more than 2 times in consultation with the referring physician will even include the child in the study so that the alliance could build process
- Children can read, understand and complete questionnaires
- No opposition made
You may not qualify if:
- Systemic form of JIA;
- Children aged under 8 years old or over 18 years;
- Child or parent does not understand French
- Refusal of participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (17)
CHU Angers
Angers, 49033, France
Hôpital Nord Franche Comté
Belfort, 90015, France
CHRU Besançon
Besançon, 25030, France
CHU Bordeaux
Bordeaux, 33076, France
CHRU Brest
Brest, 29200, France
Hôpital Femme-Mère-Enfant - HCL
Bron, 69677, France
CHU Dijon
Dijon, 21079, France
CHU Martinique
Fort-de-France, 97261, France
Hôpital Bicêtre - APHP
Le Kremlin-Bicêtre, 94275, France
CHRU Lille
Lille, 59000, France
CH Mulhouse
Mulhouse, 68100, France
CHU Nîmes
Nîmes, 30029, France
Hôpital Necker-Enfants Malades - APHP
Paris, 75015, France
CHU Poitiers
Poitiers, 86021, France
CHU Rennes
Rennes, 35000, France
CHRU Strasbourg
Strasbourg, 67098, France
CHU Nancy
Vandœuvre-lès-Nancy, 54511, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valérie Devauchelle-Pensec, Professor
University Hospital, Brest
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2016
First Posted
July 7, 2016
Study Start
October 7, 2016
Primary Completion
January 1, 2018
Study Completion
January 1, 2018
Last Updated
July 12, 2018
Record last verified: 2018-07